We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study: Slow Approval Times in EU Mean Unequal Cancer Treatment
Study: Slow Approval Times in EU Mean Unequal Cancer Treatment
February 17, 2009
Speedier regulatory and economic reviews of new cancer drugs are necessary for European patients to have equal access to cancer treatment, a study finds.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor